Genetic Engineering News, Nov 7 2006 http://www.genengnews.com/news/bnitem.aspx?name=8381289 New federal funding totaling $3.8 million will support Phase II research into breast and prostate cancer detection using a laser optoacoustic imaging technology.… Over four years of research and pilot studies by scientists at Fairway and The University of Texas Medical Branch at Galveston (UTMB) indicates the system can detect breast cancer tumors potentially as small as 2 millimeters, five time smaller than most malignant breast tumors detected currently. If this is confirmed in Phase II tests with laboratory animals, it would make it possible to identify tumors that are easily curable and currently undetectable.